Interferon Alfa With or Without Thalidomide in Treating Patients With Metastatic Kidney Cancer
NCT00027664
·
clinicaltrials.gov ↗
PHASE2
Phase
UNKNOWN
Status
90
Enrollment
OTHER
Sponsor class
Conditions
Kidney Cancer
Interventions
BIOLOGICAL:
recombinant interferon alfa
DRUG:
thalidomide
Sponsor
Cancer Research UK